Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway

BACKGROUND: Renal fibrosis is the common pathway in chronic kidney diseases progression to end-stage renal disease, but to date, no clinical drug for its treatment is approved. It has been demonstrated that the inhibitor of proto-oncogene Ras, farnesylthiosalicylic acid (FTS), shows therapeutic pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hui, Liu, Qinhui, Zhang, Ting, Zhang, Jinhang, Zhou, Jian, Jing, Xiandan, Tang, Qin, Huang, Cuiyuan, Zhang, Zijing, Zhao, Yingnan, Zhang, Guorong, Yan, Jiamin, Xia, Yan, Xu, Ying, Li, Jiahui, Li, Yanping, He, Jinhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464329/
https://www.ncbi.nlm.nih.gov/pubmed/34584410
http://dx.doi.org/10.2147/IJN.S318124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464329/
https://www.ncbi.nlm.nih.gov/pubmed/34584410
http://dx.doi.org/10.2147/IJN.S318124

Ejemplares similares